The inhibitory effect of 15-R-LXA 4 on experimental endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 145, Issue 2, 2009, Pages 200-204

  Chen, Qionghua ^a,b   Zhou, Weidong ^c   Pu, Demin ^a   Li, Zhiyong ^b   Huang, Qiansheng ^c   Chen, Qingxi ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

15 R LXA 4; Endometriosis; IL 1 ; Murine model; TNF

Indexed keywords

15 LIPOXIN A4; INTERLEUKIN 1BETA; LIPOXIN A; MESSENGER RNA; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENDOMETRIOSIS; FEMALE; GENE REPRESSION; MOUSE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 67650088090     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.05.015     Document Type: Article

References (26)

1. Giudice L.C., and Kao L.C. Endometriosis. Lancet 364 9447 (2004) 1789-1799
2. Fedele L., Somigliana E., Frontino G., Benaglia L., and Vigano P. New drugs in development for the treatment of endometriosis. Expert Opin. on Investig Drugs 17 8 (2008) 1187-1202
3. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6 12 (2005) 1191-1197
4. 4 receptor in physiologically estruscycle and pathologically endometriosis. Biomed Pharmacother 59 6 (2005) 330-338
5. Bersinger N.A., Frischknecht F., Taylor R.N., and Mueller M.D. Basal and cytokine-stimulated production of epithelial neutrophil activating peptide-78 (ENA-78) and interleukin-8 (IL-8) by cultured human endometrial epithelial and stromal cells. Fertil Steril 89 Suppl. 3 (2008) 1530-1536
6. Kondera-Anasz Z., Sikora J., Mielczarek-Palacz A., and Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 123 2 (2005) 198-203
7. Kyama C.M., Overbergh L., Debrock S., et al. Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril 85 6 (2006) 1667-1675
8. Dabrosin C., Gyorffy S., Margetts P., Ross C., and Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathoal 161 3 (2002) 909-918
9. Cao Z.Y. Chinese Obstetrics and Gynecology. In: Gao Y. (Ed). The pathology of endometriosis 2 (2004), People's Health Publishing House, Beijing 1486-1488
10. -ΔΔCT method. Methods 25 4 (2001) 402-408
11. Becker C.M., Sampson D.A., Rupnick M.A., et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 84 Suppl 2 (2005) 1144-1155
12. Hughes E., Brown J., Collins J.J., et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 3 (2007) CD000155
13. Kyama C.M., Overbergh L., Mihalyi A., et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 89 2 (2008) 301-310
14. Hull M.L., Escareno C.R., Godsland J.M., et al. Endometrial-peritoneal interactions during endometriotic lesion establishmen. Am J Pathol 173 3 (2008) 700-715
15. Guney M., Oral B., Karahan N., and Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril 89 4 (2008) 934-942
16. Serhan C.N. Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways. Annu Rev Immunol 25 (2007) 101-137
17. Haworth O., and Buckley C.D. Resolving the problem of persistence in the switch from acute to chronic inflammation. PNAS 104 52 (2007) 20647-20648
18. Schwab J.M., Nan C., Makoto A., and Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 7146 (2007) 869-874
19. Serhan C.N., Yacoubian S., and Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3 (2008) 279-312
20. Sillem M., Prifti S., Monga B., Arslic T., and Runnebaum B. Integrin-mediated adhesion of uterine endometrial cells from endometriosis patients to extracellular matrix proteins is enhanced by tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1). Eur J Obstet Gynecol Reprod Biol 87 2 (1999) 123-127
21. Yuge A., Nasu K., and Tsusue H. Regulation of contractility of cultured human endometrial stromal cells by tumor necrosis factor-alpha. Eur J Obstet Gynecol Reprod Biol 138 1 (2008) 66-70
22. Grandas O.H., Mountain D.J.H., Kirkpatrick S.S., et al. Effect of hormones on matrix metal loproteinases gene regulation in human aortic smooth muscle cells. J Surg Res 148 1 (2008) 94-99
23. Groothuis P.G., Nap A.W., Winterhager E., and Grummer R. Vascular development in endometriosis. Angiogenesis 8 2 (2005) 147-156
24. Mountain D.J.H., Singh M., and Singh K. Interleukin-1 beta-mediated inhibition of the processes of angiogenesis in cardiac microvascular endothelial cells. Life Sci 82 25-26 (2008) 1224-1230
25. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., and Fiore S. Lipoxin A(4) inhibits IL-1 beta-Induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164 5 (2000) 2660-2666
26. Petasis N.A., Akritopoulou-Zanze I., Fokin V.V., et al. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot Essent Fatty Acids 73 3-4 (2005) 301-321